tradingkey.logo
tradingkey.logo
検索

Optimi Health Ord Shs

OPTH
ウォッチリストに追加
2.250USD
+0.070+3.21%
終値 11-13 16:00(ET)
12.89M時価総額
0.00直近12ヶ月PER

Optimi Health Ord Shsについて 企業名

Optimi Health Corp. is a commercial-stage pharmaceutical company. The Company focuses on manufacturing and distributing good manufacturing practices (GMP) grade psychedelic drug products for mental health therapies. As a Health Canada-licensed pharmaceutical manufacturer, the Company produces validated Methylenedioxymethamphetamine hydrochloride (MDMA) and botanical psilocybin drug products at its GMP-compliant facilities in British Columbia, Canada. It supplies both active pharmaceutical ingredients and finished dosage forms to regulated clinical and therapeutic programs internationally, with products prescribed to patients in Australia under the country's authorized prescriber scheme and accessible in Canada through the special access program. With its vertically integrated approach, the Company owns and operates two purpose-built 10,000-square-foot licensed production sites in Princeton, British Columbia and holds a Drug Establishment Licence (DEL), as issued by Health Canada.

Optimi Health Ord Shs プロフィール

企業コード- -
会社名- -
上場日- -
最高経営責任者「CEO」- -
従業員数- -
証券種類- -
決算期末- -
本社所在地- -
都市- -
証券取引所- -
国- -
郵便番号- -
電話番号- -
ウェブサイト- -
企業コード- -
上場日- -
最高経営責任者「CEO」- -

Optimi Health Ord Shsの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. John James Wilson
Mr. John James Wilson
Chairman of the Board
Chairman of the Board
274.58K
+96.03%
Mr. Jason Mosberian
Mr. Jason Mosberian
Independent Director
Independent Director
875.00
+52.23%
Mr. Bryan Safarik
Mr. Bryan Safarik
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Mr. Jacob Safarik
Mr. Jacob Safarik
Interim Chief Financial Officer, Director
Interim Chief Financial Officer, Director
--
--
Mr. Dane Stevens
Mr. Dane Stevens
Chief Executive Officer, Chief Marketing Officer, Corporate Secretary, Director
Chief Executive Officer, Chief Marketing Officer, Corporate Secretary, Director
--
--
Dr. Michael Blough, Ph.D.
Dr. Michael Blough, Ph.D.
Chief Clinical Development Officer
Chief Clinical Development Officer
--
--
Ms. Melanie Pump
Ms. Melanie Pump
Director
Director
--
--
会社名
会社名/ポジション
ポジション
株式保有
変動額
Mr. John James Wilson
Mr. John James Wilson
Chairman of the Board
Chairman of the Board
274.58K
+96.03%
Mr. Jason Mosberian
Mr. Jason Mosberian
Independent Director
Independent Director
875.00
+52.23%
Mr. Bryan Safarik
Mr. Bryan Safarik
Chief Operating Officer, Director
Chief Operating Officer, Director
--
--
Mr. Jacob Safarik
Mr. Jacob Safarik
Interim Chief Financial Officer, Director
Interim Chief Financial Officer, Director
--
--
Mr. Dane Stevens
Mr. Dane Stevens
Chief Executive Officer, Chief Marketing Officer, Corporate Secretary, Director
Chief Executive Officer, Chief Marketing Officer, Corporate Secretary, Director
--
--
Dr. Michael Blough, Ph.D.
Dr. Michael Blough, Ph.D.
Chief Clinical Development Officer
Chief Clinical Development Officer
--
--

よくある質問

Optimi Health Ord Shsの上位5名の株主は誰ですか?

Optimi Health Ord Shsの上位5名の株主は以下のとおりです。Mr. John James Wilson
tradingkey.logo
リスク告知:当社ウェブサイト及びモバイルアプリは特定の投資商品に関する一般的な情報のみを提供しており、Finsightsは金融アドバイスや投資商品の推奨を行うものではありません。本情報の提供をもってFinsightsが投資助言を行っていると解釈されることはありません。
投資商品には元本割れを含む重大なリスクが伴い、全ての投資家に適するものではありません。なお、過去の運用実績は将来の成果を保証するものではありません。
Finsightsは、第三者広告主または提携先が当社ウェブサイト・モバイルアプリ上に広告を掲載することを許可する場合があり、これら広告主から広告への反応に基づく報酬を受けることがあります。
© 著作権: FINSIGHTS MEDIA PTE. LTD. 無断複写・転載を禁じます。